SPIA
MYOV

Steward Partners Investment Advisory’s Myovant Sciences Ltd. MYOV Stock Holding History

Steward Partners Investment Advisory’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-500
Closed -$9K – 3486
2022
Q3 		$9K Hold
500
– – ﹤0.01% 2597
2022
Q2 		$6K Hold
500
– – ﹤0.01% 2736
2022
Q1 		$7K Hold
500
– – ﹤0.01% 2802
2021
Q4 		$8K Buy
+500
New +$9.54K ﹤0.01% 2703

Other funds holding MYOV

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Steward Partners Investment Advisory's MYOV Position: Q4 2022 in Review

Steward Partners Investment Advisory sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 500 shares — an estimated $9K sold.

Steward Partners Investment Advisory first reported a position in MYOV in Q4 2021 and held it in 4 quarters. The position peaked at $9K in Q3 2022. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • Steward Partners Investment Advisory reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 500 Myovant Sciences Ltd. shares in Q4 2022, an estimated $9K.
  • Steward Partners Investment Advisory first reported a position in Myovant Sciences Ltd. in Q4 2021 and held it in 4 quarters.
  • Steward Partners Investment Advisory's Myovant Sciences Ltd. position peaked at $9K in Q3 2022.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2022, filed 15 Feb 2023.